Subscribe To
Coca-cola stock rises toward 8-month high after profit and revenue rose above forecasts, and full-year outlook maintained
Shares of Coca-Cola Co. KO rose 0.9% toward an eight-month high in premarket trading Monday, after the beverage giant reported first-quarter profit an...
April 24, 2023, 7:05 am
Wm argyle asks broadwind to disclose profitability guidance, too
MILWAUKEE, April 21, 2023 (GLOBE NEWSWIRE) — WM Argyle Fund, LLC (“WM Argyle” or the “Fund”), one of the largest investors in Broadwind, Inc...
April 21, 2023, 6:50 pm
Taiwan semiconductor manufacturing company lowers revenue outlook amid weaker chip demand
Taiwan Semiconductor Manufacturing Co (TSMC) has lowered its revenue outlook for the current quarter and full<...
April 20, 2023, 9:01 am
Rba review recommends a board with more expertise
The independent review of the Reserve Bank of Australia (RBA) has been released. Recommended creating a specialist board to manage monetary policy tha...
April 20, 2023, 12:05 am
Malaga financial corporation reports 23% increase in yoy first quarter earnings
PALOS VERDES ESTATES, Calif., April 19, 2023 (GLOBE NEWSWIRE) — Malaga Financial Corporation “Company” (OTCPink:MLGF), the parent company of Mal...
April 19, 2023, 9:02 pm
James hardie industries to announce fourth quarter and fiscal year 2023 financial results on 16 may 2023
SYDNEY & CHICAGO--(BUSINESS WIRE)--James Hardie Industries plc (ASX: JHX; NYSE: JHX) will announce financial results, for its fourth quarter ...
April 19, 2023, 7:00 pm
United airlines forecasts profit above expectations, and stock rises
United Airlines Holdings Inc. on Tuesday forecast second-quarter and full-year per-share profit that we...
April 18, 2023, 4:24 pm
Jushi holdings hails passage of medical cannabis bills in virginia
Jushi Holdings Inc (CSE:JUSH, OTCQX:JUSHF) has announced support and appreciation for the Virginia General Assembly's passage of medical cannabis and ...
April 18, 2023, 8:46 am
Saratoga investment corp. to report fiscal fourth quarter and full year 2023 financial results and hold conference call
NEW YORK, April 18, 2023 (GLOBE NEWSWIRE) -- Saratoga Investment Corp. (NYSE:SAR), a business development company, will report its financial results f...
April 18, 2023, 8:30 am
Posabit to host fourth quarter and fy 2022 earnings conference call
TORONTO & SEATTLE--(BUSINESS WIRE)--POSaBIT Systems Corporation (CSE: PBIT, OTC: POSAF) (the “Company” or “POSaBIT”), a leading provider of pa...
April 18, 2023, 7:30 am
Cirrus logic to report fourth quarter and full fiscal year 2023 results
AUSTIN, Texas--(BUSINESS WIRE)--Cirrus Logic, Inc. (NASDAQ: CRUS) today announced that the company will post its fourth quarter ...
April 17, 2023, 4:00 pm
Gsr ii meteora acquisition corp. announces filing of amended proxy statement; bitcoin depot reports strong fourth quarter and full-year 2022 results
Bitcoin Depot Delivers Revenue Growth of 18% and Gross Profit Growth of 24% for 2022 Strengthens U.S. Footprint and Continues Business Momentum with M...
April 17, 2023, 12:05 pm
Infosys: too risky due to financial issues and high costs
On April 13, Infosys ( INFY , Financial) reported financial results for its fourth quarter and full yea...
April 17, 2023, 11:57 am
Vaxcyte to host webcast and conference call to discuss results from phase 2 study of its 24-valent pneumococcal conjugate vaccine candidate in adults aged 65 and older and full six-month safety data f
SAN CARLOS, Calif., April 16, 2023 (GLOBE NEWSWIRE) — Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fid...
April 16, 2023, 9:00 pm
Vaxcyte to host webcast and conference call to discuss results from phase 2 study of its 24-valent pneumococcal conjugate vaccine candidate in adults aged 65 and older and full six-month safety data f
SAN CARLOS, Calif., April 16, 2023 (GLOBE NEWSWIRE) — Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fid...
April 16, 2023, 9:00 pm
Vaxcyte to host webcast and conference call to discuss results from phase 2 study of its 24-valent pneumococcal conjugate vaccine candidate in adults aged 65 and older and full six-month safety data f
SAN CARLOS, Calif., April 16, 2023 (GLOBE NEWSWIRE) — Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fid...
April 16, 2023, 9:00 pm
Vaxcyte to host webcast and conference call to discuss results from phase 2 study of its 24-valent pneumococcal conjugate vaccine candidate in adults aged 65 and older and full six-month safety data f
SAN CARLOS, Calif., April 16, 2023 (GLOBE NEWSWIRE) — Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fid...
April 16, 2023, 9:00 pm
Vaxcyte to host webcast and conference call to discuss results from phase 2 study of its 24-valent pneumococcal conjugate vaccine candidate in adults aged 65 and older and full six-month safety data f
SAN CARLOS, Calif., April 16, 2023 (GLOBE NEWSWIRE) — Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fid...
April 16, 2023, 9:00 pm
Vaxcyte to host webcast and conference call to discuss results from phase 2 study of its 24-valent pneumococcal conjugate vaccine candidate in adults aged 65 and older and full six-month safety data f
SAN CARLOS, Calif., April 16, 2023 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fide...
April 16, 2023, 5:00 pm
Vaxcyte to host webcast and conference call to discuss results from phase 2 study of its 24-valent pneumococcal conjugate vaccine candidate in adults aged 65 and older and full six-month safety data f
SAN CARLOS, Calif., April 16, 2023 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fide...
April 16, 2023, 5:00 pm